Kamama, Rosda .
HRN: 21-32-03 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2022
CEFUROXIME 500MG (TAB)
05/08/2022
05/14/2022
ORAL
500mg/tab
BID
S/P LTCS
Waiting Final Action